Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19)

NCT04685655 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT04685655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04685655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19)
Lead sponsor
Heidelberg University
Phase
Not applicable
Overall status
Terminated
Start date
January 7, 2020
Completion date
April 30, 2023
Enrollment
67 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, therapeutic plasma exchange